⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 19, 2024JAMA

Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions?

View at Publisher

Ask AI

Bookmark

Share

Abstract

This Medical News story examines other potential uses of GLP-1 receptor agonists, the popular type 2 diabetes and weight-loss drugs.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rita Rubin (2024) studied this question.

synapsesocial.com/papers/68e6e657b6db643587661331 https://doi.org/10.1001/jama.2024.1017

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The New American Addiction: How Weight-Loss Drugs Could Create the Next Epidemic2025
2What makes GLP1 receptor agonist drugs so effective for obesity?2025
3Injections for weight loss: what’s new in GLP-1 RAs for obesity treatment – review2024 · 1 citations
4GLP-1 Receptor Agonists Beyond Glycemic Control: Clinical Implications in Neurodegenerative Disease and Substance Use DisordersHuman Clinical Trial · 2026
5Role of GLP Agonists in treatment of diabetes and metabolic disorders: A review of underlying mechanismsClinical Trial · 2026

More related papers

Not Just for Diabetes: The Next Frontier for GLP-1 Agonists2026
GLP-1 Receptor Agonists and Research to Treat Overeating and Substance Use Disorders2025
The multifaceted effects of semaglutide: exploring its broad therapeutic applications2025

More from JAMA

Pregnancy Outcomes After Living Kidney DonationThu,
Obesity in Children Aged 2 to 12 YearsWed,